Acute lymphoblastic leukaemia trials in Japan
9 trials · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 2/3Taking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Bunkyo, Minato
- Age
- 12 years and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - Phase 4Taking peopleAsciminib Roll-over Study
- Where
- Kobe
- Age
- 7 years to 100 years
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - Phase 1/2Taking peopleStudy of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression
- Where
- Bunkyō City, Kashiwa, Okayama
- Age
- 16 years and over
- People
- 85 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07155226 · EU 2025-521299-76-00 - Phase 3Taking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Chiba, Ehime, Hiroshima, Hokkaido, Hyōgo, Kagoshima, Kanagawa, Kyoto, Mie, Nagoya, Osaka, Saitama, Shizuoka, Tōhoku, Tokyo
- Age
- 1 day to 1 year
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - Phase 1/2Taking peopleStudy of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia
- Where
- Bunkyō City, Chūōku, Kashiwa
- Age
- 12 years and over
- People
- 83 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT07109219 · EU 2025-522372-93-00 - Phase 1/2Taking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Bunkyō City, Chiba, Chūōku, Fukuoka, Kashiwa, Kyoto, Okayama, Osaka, Sapporo, Toyohashi, Yamagata
- Age
- 12 years and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - Phase 3Taking peopleStudy of Out of Specification for Tisagenlecleucel
- Where
- Aomori, Bunkyo Ku, Chiba, Chuo Ku, Fuchū, Fukuoka, Gifu, Hamamatsu, Hiroshima, Ishikawa, Izumi, Izumisano, Izumo, Kita-gun, Kobe, Kumamoto, Kurashiki, Kyoto, Matsumoto, Minato Ku, Nagasaki, Nagoya, Niigata, Nishinomiya, Okayama, Osaka, Saitama, Sakai, Sapporo, Sendai, Setagaya-ku, Shinjuku Ku, Suita, Tōon, Tsu, Tsukuba, Wakayama, Yokohama, Yufu
- Age
- 0 years to 100 years
- People
- 200 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04094311 - Phase 1/2Taking peopleA Phase I/II Study of OJP-001 in Patients With Adult T-cell Leukemia/Lymphoma
- Where
- Fukuoka, Kagoshima, Miyazaki, Nagasaki, Sapporo
- Age
- 20 years to 85 years
- People
- 49
- Run by
- Otsuka Medical Devices Co., Ltd. Japan
See details and how to joinNCT07075328 - Phase 1/2Taking peopleA Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
- Where
- Bunkyō City, Bunkyo-ku, Fukuoka, Fukushima, Hokkaido, Isehara-Shi, Kashiwa-shi, Miyagi, Nagasaki, Okayama, Osaka, Yoshida-gun
- Age
- 12 years and over
- People
- 606 worldwide
- Run by
- Sumitomo Pharma America, Inc.
See details and how to joinNCT04988555